PRP and Stem Cell Injections for Joint Pain: What the Evidence Actually Shows

If you have been researching alternatives to joint surgery, you have almost certainly encountered marketing for platelet-rich plasma (PRP) injections and stem cell therapy. The claims range from cautious ("may reduce inflammation") to extraordinary ("regenerate your cartilage and avoid surgery"). The price tags range from $500 to $10,000 per injection, and insurance almost never covers them.

This article reviews what the clinical evidence actually shows for these biologic treatments, who they might help, and where the line falls between legitimate medicine and expensive hope.

Platelet-rich plasma (PRP)

PRP is made from your own blood. A sample is drawn, centrifuged to concentrate the platelets (which contain growth factors involved in tissue healing), and injected back into the affected joint. The theory is that concentrated growth factors will stimulate healing and reduce inflammation.

What the evidence shows

For knee osteoarthritis, PRP has the strongest evidence base of any biologic injection. Multiple randomized controlled trials and meta-analyses have found that PRP provides greater and longer-lasting pain relief than hyaluronic acid injections or saline placebo for mild to moderate knee arthritis. The effect typically lasts 6 to 12 months, and some patients respond to repeated injections over several years.

The caveats are important. PRP does not regenerate lost cartilage. Imaging studies consistently show that joint structure does not improve after PRP, even when pain decreases. The benefit is anti-inflammatory and possibly protective of remaining cartilage, not regenerative. PRP works best in mild to moderate arthritis (Kellgren-Lawrence Grade 2-3). For bone-on-bone arthritis (Grade 4), the evidence is weak, and patients with severe arthritis rarely get meaningful relief from PRP.

For hip arthritis, the evidence is thinner. A few small studies suggest modest benefit, but no large randomized trial has been completed. For shoulder conditions (rotator cuff tears, labral tears), PRP is sometimes used as an adjunct to surgical repair, with mixed evidence on whether it improves healing rates.

Cost and insurance

PRP injections typically cost $500 to $1,500 per injection and are not covered by most insurance plans. Some patients require two to three injections for optimal effect. Compared to a $50,000 knee replacement, a $1,500 PRP injection that delays surgery by one to two years can be a reasonable value proposition for the right patient.

Stem cell therapy

The term "stem cell therapy" in the orthopedic clinic usually refers to injections of concentrated bone marrow aspirate (BMAC), adipose-derived stromal cells (from fat tissue), or, less commonly, amniotic tissue products. These are marketed as containing stem cells capable of regenerating cartilage and healing damaged joints.

What the evidence shows

The honest assessment: the clinical evidence for stem cell therapy in joint arthritis is preliminary and does not support the claims made by most clinics offering it. The number of cells that qualify as true stem cells in most preparations is small. No large, well-designed randomized controlled trial has demonstrated that stem cell injections regenerate cartilage in arthritic joints. The FDA has issued multiple warnings about clinics making unsubstantiated claims about stem cell treatments.

That does not mean these injections have zero effect. Bone marrow aspirate concentrate (BMAC) contains growth factors, anti-inflammatory proteins, and some progenitor cells that may provide symptomatic relief similar to PRP. Some studies show modest pain improvement at 6 to 12 months. But the evidence does not support the "regeneration" narrative that clinics use to justify $5,000 to $10,000 price tags.

Red flags to watch for

Be cautious of any clinic that claims stem cells will regrow your cartilage (not supported by current evidence), charges more than $3,000 to $5,000 per injection without published outcome data, uses cells from sources other than your own body without an FDA-approved protocol, promotes stem cell therapy as a guaranteed alternative to surgery, or pressures you to commit to multiple sessions during your first visit.

Who should consider biologics

PRP is a reasonable consideration for patients with mild to moderate arthritis who want to delay joint replacement, patients who have had some benefit from cortisone injections but want a longer-lasting option, younger patients who are too young for replacement and want to manage symptoms for several more years, and athletes or active individuals looking to extend their competitive window before surgery becomes necessary.

Biologics are not a substitute for joint replacement in patients with severe, bone-on-bone arthritis. If your surgeon has recommended replacement and conservative treatments including injections have failed, PRP or stem cells are unlikely to change the trajectory.

Frequently asked questions

Will PRP help me avoid knee replacement?

PRP may delay replacement by one to several years in patients with mild to moderate arthritis. It does not reverse arthritis or eliminate the eventual need for replacement in patients with progressive disease. Think of it as buying time, not a cure.

Are stem cell injections FDA approved?

No stem cell injection for joint arthritis has received FDA approval. Clinics offering these treatments are operating under regulatory frameworks that permit the use of a patient's own cells with minimal manipulation. Products marketed as containing "stem cells" from donor tissue are subject to FDA regulation, and several have received warning letters.